RecruitingNot ApplicableNCT07343843

Virtual Reality Versus Intravenous Dexmedetomidine on Maternal Anxiety, Stress, Hemodynamics, and Neonatal Outcomes During Cesarean Section

Effect of Virtual Reality Versus Intravenous Dexmedetomidine on Maternal Anxiety, Stress, Hemodynamics, and Neonatal Outcomes During Cesarean Section


Sponsor

Benha University

Enrollment

52 participants

Start Date

Jan 17, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to compare the efficacy of intravenous dexmedetomidine infusion versus virtual reality (VR) in reducing maternal anxiety, stress, and hemodynamic instability during cesarean section and their effects on neonatal outcome as respiration and heart rate.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing two methods to help reduce anxiety and stress in pregnant women having a planned C-section. One group will use a virtual reality headset during the procedure, and the other will receive a mild sedative medication (dexmedetomidine) given through an IV. Researchers also want to see how each method affects the mother's blood pressure and heart rate, and whether it has any impact on the baby. **You may be eligible if...** - You are over 18 years old - You are scheduled for a planned (elective) C-section - You are receiving spinal or epidural anesthesia for the procedure - You are willing to participate and sign consent **You may NOT be eligible if...** - You have a reason you cannot have spinal/epidural anesthesia (e.g., severe clotting disorder, local infection) - You have a psychiatric condition - You have vision or hearing impairment - You have epilepsy, cognitive impairment, or claustrophobia - You have signs of active labor, pregnancy complications, or fetal distress Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDexmedetomidine

Following confirmation of adequate spinal anesthesia, dexmedetomidine will be administered as an intravenous infusion of 0.2-0.4µg/kg/hr until abdominal closure.

OTHERVirtual reality

Participants will be fitted with virtual reality headsets immediately after the establishment of spinal anesthesia. The headsets will display calming immersive audiovisual content, and participants will continue wearing them throughout the entire procedure until skin closure.


Locations(1)

Benha University

Banhā, Benha, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07343843


Related Trials